Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer

European Journal of Cancer Prevention

Volumn 21, Issue 4, 2012, Pages 375-386

  Lipworth, Loren ^a,b   Sonderman, Jennifer S ^a   Tarone, Robert E ^a,b   McLaughlin, Joseph K ^a,b  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acrylamide; breast; cancer; diet; endometrial; epidemiology; ovarian; review

Indexed keywords

ACRYLAMIDE; TOBACCO SMOKE;

BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DIETARY INTAKE; ENDOMETRIUM CANCER; EPIDEMIOLOGY; ESOPHAGUS CANCER; HUMAN; KIDNEY CARCINOMA; LARYNX CANCER; LUNG CANCER; OROPHARYNX CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; SMOKING; STOMACH CANCER;

ACRYLAMIDE; DIET SURVEYS; EATING; EPIDEMIOLOGIC STUDIES; FOOD CONTAMINATION; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 84861824923     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283529b64     Document Type: Review

References (59)

1. Arab L (2010). Epidemiologic evidence on coffee and cancer. Nutr Cancer 62:271-283.
2. Baron JA (1996). Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 52:58-73.
3. Bjellaas T, Olesen PT, Frandsen H, Haugen M, Stolen LH, Paulsen JE, et al. (2007). Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol Sci 98:110-117.
4. Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, La Vecchia C, et al. (2009). Coffee drinking and endometrial cancer risk: a meta-analysis of observational studies. Am J Obstet Gynecol 200:130-135.
5. Bull RJ, Robinson M, Laurie RD, Stoner GD, Greisiger E, Meier JR, et al. (1984). Carcinogenic effect of acrylamide in Sencar and A/J mice. Cancer Res 44:107-111.
6. Burley VJ, Greenwood DC, Hepworth SJ, Fraser LK, de Kok TM, van Breda SG, et al. (2010). Dietary acrylamide intake and risk of breast cancer in the UK women's cohort. Br J Cancer 103:1749-1754.
7. Collins JJ, Swaen GMH, Marsh GM, Utidjian HMD, Caporossi JC, Lucas LJ (1989). Mortality patterns among workers exposed to acrylamide. J Occup Environ Med 31:614-617.
8. Fennell TR, Sumner SCJ, Snyder RW, Burgess J, Spicer R, Bridson WE, et al. (2005). Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85:447-459.
9. Fennell TR, Sumner SCJ, Snyder RW, Burgess J, Friedman MA (2006). Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol Sci 93:256-267.
10. Fuhr U, Boettcher MI, Kinzig-Schippers M, Weyer A, Jetter A, Lazar A, et al. (2006). Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15:266-271.
11. Gargas ML, Kirman CR, Sweeney LM, Tardiff RG (2009). Acrylamide: consideration of species differences and nonlinear process in estimating risk and safety for human ingestion. Food Chem Toxicol 47:760-768.
12. Hagmar L, Wirfält E, Paulsson B, Törnqvist M (2005). Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat Res 580:157-165.
13. Hirvonen T, Kontto J, Jestoi M, Valsta L, Peltonen K, Pietinen P, et al. (2010). Dietary acrylamide intake and the risk of cancer among Finnish male smokers. Cancer Causes Control 21:2223-2229.
14. Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA (2007). A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian and breast cancer. Cancer Epidemiol Biomarkers Prev 16:2304-2313.
15. Hogervorst JG, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2008a). Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87:1428-1438.
16. Hogervorst JG, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2008b). Dietary acrylamide intake is not associated with gastrointestinal cancer risk. J Nutr 138:2229-2236.
17. Hogervorst JG, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2009a). Lung cancer risk in relation to dietary acrylamide intake. J Natl Cancer Inst 101:651-662.
18. Hogervorst JG, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2009b). Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev 18:1663-1666.
19. Hogervorst JGF, Baars B-J, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2010). The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 40:485-512.
20. International Agency for Research on Cancer (1994). Acrylamide. IARC monographs on the evaluation of carcinogenic risks to humans, volume 60, some industrial chemicals. Lyon, France: IARC. pp. 389-433.
21. Je Y, Hankinson SE, Tworoger SS, DeVivo I, Giovannucci E (2011). A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev 20:2487-2495.
22. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, et al. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154-168.
23. Klaunig JE (2008). Acrylamide carcinogenicity. J Agric Food Chem 56: 5984-5988.
24. Konings EJM, Hogervorst JGF, van Rooij L, Schouten LJ, Sizoo EA, van Egmond HP, et al. (2010). Validation of a database on acrylamide for use in epidemiologic studies. Eur J Clin Nutr 64:534-540.
25. Kopp EK, Dekant W (2009). Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses. Toxicol Appl Pharmacol 235:135-142.
26. Larsson SC, Akesson A, Bergkvist L, Wolk A (2009a). Dietary acrylamide intake and risk of colorectal cancer in a prospective cohort of men. Eur J Cancer 45:513-516.
27. Larsson SC, Akesson A, Wolk A (2009b). Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am J Epidemiol 169:376-381.
28. Larsson SC, Akesson A, Wolk A (2009c). Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 18:994-997.
29. Larsson SC, Akesson A, Wolk A (2009d). Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 18:1939-1941.
30. Larsson SC, Hakansson N, Akesson A, Wolk A (2009e). Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 124:1196-1199.
31. Lin Y, Lagergren J, Lu Y (2011). Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden. Int J Cancer 128:676-681.
32. Marsh GM, Lucas LJ, Youk AO, Schall LC (1999). Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup Environ Med 56:181-190.
33. Marsh GM, Youk AO, Buchanich JM, Kant IJ, Swaen G (2007). Mortality patterns among workers exposed to acrylamide: updated follow up. J Occup Environ Med 49:82-95.
34. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K (2003a). Reply: dietary acrylamide and cancer risk: additional data on coffee. Br J Cancer 89:775-776.
35. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K (2003b). Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88:84-89.
36. Mucci LA, Lindblad P, Steineck G, Adami HO (2004). Dietary acrylamide and risk of renal cell cancer. Int J Cancer 109:774-776.
37. Mucci LA, Sandin S, Bälter K, Adami HO, Magnusson C, Weiderpass E (2005). Acrylamide intake and breast cancer risk in Swedish women. JAMA 293:1326-1327.
38. Mucci LA, Adami HO, Wolk A (2006). Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 118:169-173.
39. Olesen PT, Olsen A, Frandsen H, Frederiksen K, Overvad K,Tjønneland A (2008). Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health study. Int J Cancer 122: 2094-2100.
40. Pedersen GS, Hogervorst JGF, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA (2009). Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat 122:199-210.
41. Pelucchi C, Galeone C, Dal Maso L, Talamini R, Montella M, Ramazzotti V, et al. (2007). Dietary acrylamide and renal cell cancer. Int J Cancer 120: 1376-1377.
42. Pelucchi CC, Galeone C, Levi F, Negri E, Franceschi S, Talamini R, et al. (2006). Dietary acrylamide and human cancer. Int J Cancer 118:467-471.
43. Pelucchi CC, Galeone C, Talamini R, Negri E, Polesel J, Serraino D, et al. (2011a). Dietary acrylamide and pancreatic cancer risk in an Italian case-control study. Ann Oncol 22:910-1915.
44. Pelucchi CC, La Vecchia C, Bosetti C, Boyle P, Boffetta P (2011b). Exposure to acrylamide and human cancer-a review and meta-analysis of epidemiologic studies. Ann Oncol 22:1487-1499.
45. Rice JM (2005). The carcinogenicity of acrylamide. Mutat Res 580:3-20.
46. Schettgen T, Rossbach B, Kütting B, Letzel S, Drexler H, Angerer J (2004). Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 207:531-539.
47. Schouten LJ, Hogervorst JGF, Konings EJM, Goldbohm RA, van den Brandt PA (2009). Dietary acrylamide intake and the risk of head-neck and thyroid cancers: results from the Netherlands Cohort Study. Am J Epidemiol 170: 873-884.
48. Sobel W, Bond GG, Parsons TW, Brenner FE (1986). Acrylamide cohort mortality study. Br J Ind Med 43:785-788.
49. Svensson K, Abramsson L, Becker W, Glynn A, Hellenäs K-E, Lind Y, et al. (2003). Dietary intake of acrylamide in Sweden. Food Chem Toxicol 41:1581-1586.
50. Swaen GMH, Haidar S, Burns CJ, Bodner K, Parsons T, Collins JJ, et al. (2007). Mortality study update of acrylamide workers. Occup Environ Med 64: 396-401.
51. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M (2000). Acrylamide: a cooking carcinogen? Chem Res Toxicol 13:517-522.
52. Van den Brandt PA, Goldbohm RA, van't Veer P, Volovics A, Hermus RJJ, Sturmans F (1990). A large-scale prospective cohort study on diet and cancer in the Netherlands. J Clin Epidemiol 43:285-295.
53. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. (2004). Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96:99-106.
54. Wilson KM, Bä lter K, Adami HO, Grö nberg H, Vikström AC, Paulsson B, et al. (2009a). Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer 124: 2384-2390.
55. Wilson KM, Mucci LA, Cho E, Hunter DJ, Chen WY, Willett WC (2009b). Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol 169:954-961.
56. Wilson KM, Vesper HW, Tocco P, Sampson L, Rosén J, Hellenäs KE, et al. (2009c). Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide. Cancer Causes Control 20:269-278.
57. Wilson KM, Mucci LA, Rosner BA, Willett WC (2010). A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancer. Cancer Epidemiol Biomarkers Prev 19:2503-2515.
58. Wilson KM, Giovannucci E, Stampfer MJ, Mucci LA (2011). Dietary acrylamide and risk of prostate cancer. Int J Cancer [Aug 22 Epub ahead of print].
59. Yu X, Bao Z, Zou J, Dong J (2011). Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11:96.